Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Synta Pharmaceuticals Corp

+ Add to Watchlist

SNTA:US

2.2200 USD 0.0500 2.20%

As of 20:10:00 ET on 05/26/2015.

Company Profile for Synta Pharmaceuticals Corp (SNTA)

Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.

Contact Information

Synta Pharmaceuticals Corp

45 Hartwell Avenue
Lexington, MA 02421
United States
Phone: 1-781-274-8200
Fax: 1-781-274-8228

Key Executives for Synta Pharmaceuticals Corp (SNTA)

Chen SchorPresident/CEOMarc R SchneebaumSenior VP/CFO
Vojo VukovicSenior VP/Chief Medical OfcrArthur McMahon "Art"Senior VP:People Operations
Wendy E RiederVP/Secretary/Genral CounselMindy S KohlAssociate Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil